Japanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Torii Pharmaceutical

Market Cap: JP¥126.3b

Manufactures and markets pharmaceutical products in Japan.

Stella Pharma

Market Cap: JP¥11.3b

Engages in the research, development, manufacturing, and distribution of pharmaceuticals.

Kubota Pharmaceutical Holdings

Market Cap: JP¥2.6b

Develops portfolio of drugs and devices worldwide.

Sawai Group Holdings

Market Cap: JP¥226.3b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Pharma Foods International

Market Cap: JP¥25.5b

Engages in the development and sale of functional food ingredients in Japan.

Otsuka Holdings

Market Cap: JP¥3.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

NANO MRNALtd

Market Cap: JP¥9.5b

Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.

RaQualia Pharma

Market Cap: JP¥7.8b

Engages in the research and development of pharmaceutical compounds worldwide.

Linical

Market Cap: JP¥6.8b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Daiichi Sankyo Company

Market Cap: JP¥6.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Human Metabolome Technologies

Market Cap: JP¥4.0b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Precision System Science

Market Cap: JP¥5.2b

Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.

Ono Pharmaceutical

Market Cap: JP¥823.9b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Hisamitsu Pharmaceutical

Market Cap: JP¥327.3b

Manufactures and sells pharmaceuticals in Japan.

Tsumura

Market Cap: JP¥334.2b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Cyfuse Biomedical K.K

Market Cap: JP¥8.2b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

PeptiDream

Market Cap: JP¥242.4b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Healios K.K

Market Cap: JP¥31.0b

Engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Chiome Bioscience

Market Cap: JP¥9.1b

Engages in the research and development of drug discovery technology platforms worldwide.

Kohjin Bio

Market Cap: JP¥8.5b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Daito PharmaceuticalLtd

Market Cap: JP¥31.1b

Manufactures and sells pharmaceutical products worldwide.

Japan Tissue Engineering

Market Cap: JP¥21.1b

Engages in the regenerative medicine business in Japan.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥67.4b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Takeda Pharmaceutical

Market Cap: JP¥6.5t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Eisai

Market Cap: JP¥1.1t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥53.1b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

AnGes

Market Cap: JP¥22.6b

Engages in the research and development of gene-based medical products.

Tsubota Laboratory

Market Cap: JP¥9.7b

Engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

KYORIN Pharmaceutical

Market Cap: JP¥84.8b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Delta-Fly Pharma

Market Cap: JP¥4.4b

Develops anticancer drugs.

Astena Holdings

Market Cap: JP¥18.8b

Manufactures and sells medicine-related products in Japan.

3-D Matrix

Market Cap: JP¥14.1b

Develops self-assembling peptide technology in Japan and internationally.

Cuorips

Market Cap: JP¥64.5b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.